Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of oxygen and midazolam is commonly used in medical settings, particularly for sedation during procedures. This combination leverages the sedative properties of midazolam while maintaining adequate oxygenation for patient safety. ## Pharmacology and Uses Midazolam is a potent benzodiazepine with sedative, anxiolytic, and amnestic properties. When combined with oxygen, it provides a deeper form of sedation while reducing the risk of respiratory depression that might occur with midazolam alone[1][2]. This combination is particularly valuable in pediatric dentistry, where managing anxiety is crucial for successful treatment[2]. The combination works well because: - Oxygen supplementation helps prevent hypoxia that might occur with midazolam-induced respiratory depression[1] - Studies have shown that coadministration of nitrous oxide/oxygen with midazolam does not result in hypercarbia (elevated CO2 levels), which is an early indicator of respiratory depression[1] - A deeper form of sedation can be achieved for pediatric patients when using this combination[2] ## Administration Routes Midazolam can be administered through various routes when used with oxygen: - Intravenous (IV) - Intramuscular (IM) - Oral - Submucosal - Buccal Oxygen is typically administered via inhalation, often through a nasal cannula or mask during procedures[5][7]. ## Clinical Applications This combination is primarily used for: 1. **Procedural sedation** - Particularly for diagnostic, therapeutic, or endoscopic procedures[6][7] 2. **Pre-operative sedation** - To reduce anxiety and provide amnesia before surgery[7][8] 3. **Component of balanced anesthesia** - Midazolam can be used as a component of intravenous supplementation of nitrous oxide and oxygen[6] 4. **Pediatric dental procedures** - To manage anxiety and provide sedation in children undergoing dental work[2][3] ## Safety Considerations When using this combination, healthcare providers must be aware of: - Potential for respiratory depression, especially with higher doses of midazolam[5] - Need for careful monitoring of vital signs during administration[5] - Risk of increased CNS inhibition when midazolam is combined with other CNS depressants[3] - Availability of flumazenil (a benzodiazepine antagonist) for reversal of adverse events[3] The combination appears to provide better safety than midazolam alone, as one study demonstrated that arterial CO2 levels increased in midazolam-exposed animals breathing room air, but not in those exposed to nitrous oxide/oxygen[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Midazolam and Oxygen.